Manchester, United Kingdom

John Ferguson

This inventor holds 1 USPTO granted patent. Top assignee: Ufc Corporation. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Ferguson. Retrieved from https://idiyas.com/inventor/john-ferguson-k01pkzk5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: John Ferguson: Innovator in Pharmaceutical Chemistry

Introduction

John Ferguson is a notable inventor based in Manchester, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes related to morphine derivatives. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Ferguson's most recent patent is titled "Process for making morphine-6-glucuronide and its analogues using haloglucuronate ester intermediates." This patent highlights his innovative approach to synthesizing important compounds that can have therapeutic applications. He holds 1 patent in this area, reflecting his commitment to research and development in pharmaceuticals.

Career Highlights

John Ferguson is currently employed at Ufc Corporation, where he continues to work on groundbreaking projects in the pharmaceutical industry. His role at the company allows him to collaborate with other talented professionals and contribute to the advancement of drug development.

Collaborations

Ferguson has worked alongside esteemed colleagues such as Feodor Scheinmann and Andrew Valentine Stachulski. These collaborations have enriched his research and have led to innovative solutions in the field of pharmaceutical chemistry.

Conclusion

John Ferguson is a dedicated inventor whose work in pharmaceutical chemistry has the potential to impact medical treatments significantly. His innovative processes and collaborations with other experts in the field underscore his commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…